Work

Supplementary Figure 3 from An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas

Year: 2023

Type: supplementary-materials

Abstract: PDF file, 239K, The components of the vaccine/Fc-OX40L treatment were broken down to determine which components were necessary for maximal effect.

DOI: 10.1158/1078-0432.22450845.v1

Authors: Katherine A. Murphy, Melissa G. Lechner, Flavia E. Popescu, Jessica Bedi, Stacy A. Decker, Peisheng Hu, Jami R. Erickson, M. Gerard O'Sullivan, Lauryn Swier, Andres M. Salazar, Michael R. Olin, Alan L. Epstein, John R. Ohlfest

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361908497

Cites:

Cited by:

Related to: 10